Survival Outcomes Based on Axillary Surgery in Ductal Carcinoma In Situ: A Nationwide Study From the Korean Breast Cancer Society

Journal of Breast Cancer · Published 2024-01-01 · DOI 10.4048/jbc.2023.0221

Authors being retrieved — see the publisher record. https://doi.org/10.4048/jbc.2023.0221

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Diet and Breast Cancer Survivorship: A Scoping Review · Journal of Breast Cancer · 2026 · Same journal
• Loss of Nuclear Profilin 1 Triggers Oncogenic Reprogramming of Mammary Epithelial Cells Through Dysregulated DNA Replication in Breast Cancer · Journal of Breast Cancer · 2025 · Same journal
• Identification of Poor Prognostic Markers in Triple-Negative Breast Cancer Using Whole Exome Sequencing · Journal of Breast Cancer · 2025 · Same journal
• Neoadjuvant Chemotherapy Is Effective in Those Infected With SARS-CoV-2: The Real-World Experience of a Large Chinese Breast Cancer Center · Journal of Breast Cancer · 2024 · Same journal
• Prognostic Value of Neutrophil-Lymphocyte Ratio Change After Short-Term Chemotherapy in De Novo Stage IV Breast Cancer Patients · Journal of Breast Cancer · 2025 · Same journal
• Challenges in Identifying Sentinel Lymph Nodes in Early Breast Cancer Patients: Should We Opt for Standard Axillary Lymph Node Dissection? · Journal of Breast Cancer · 2026 · Same journal
• Undifferentiated Pleomorphic Sarcoma Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma · Journal of Breast Cancer · 2024 · Same journal
• Clinical Outcomes of Lobular Carcinoma In Situ : Risk of Invasive Cancer Development · Journal of Breast Cancer · 2026 · Same journal
• Sentinel Lymph Node Analysis in Patients With Breast Cancer Revealed Alterations in T Cells Subset · Journal of Breast Cancer · 2026 · Same journal
• Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response · Journal of Breast Cancer · 2024 · Same journal